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ABSTRACT
We observed previously that glucose deprivation induces cy-
totoxicity, increases the intracellular levels of hydroperoxide,
and activates the stress-activated protein kinase (SEK) path-
way. In this study, we hypothesized that 1-methylpropyl 2-im-
idazolyl disulfide (IV-2), a thioredoxin (TRX) inhibitor, augments
glucose deprivation-induced cytotoxicity by promoting c-Jun
N-terminal kinase (JNK) activation. Human prostatic carcinoma
DU-145 cells were exposed to glucose-free medium containing
various concentrations of IV-2 (10–50 M). Glucose deprivation
alone or IV-2 alone induced minimal cytotoxicity within 7 h.
However, the combination of glucose deprivation and IV-2 in-
creased cell death in a dose-dependent manner. The cytotox-
icity was suppressed by treatment with an antioxidant, N-
acetyl-L-cysteine or overexpressing TRX. The combined
glucose deprivation and IV-2 treatment also promoted glucose
deprivation-induced JNK1 activation by disrupting the interac-
tion between TRX and apoptosis signal-regulating kinase 1
(ASK1). Overexpression of the JNK1 dominant-negative mutant
inhibited the activation of the SEK pathway and protected cells
from glucose deprivation and IV-2–induced cytotoxicity. There-
fore, IV-2 enhances glucose deprivation-induced cytotoxicity
by promoting glucose deprivation-induced activation of the
ASK1-SEK1-JNK1 pathway.
We observed previously that glucose deprivation increases
the intracellular levels of hydroperoxide and oxidized gluta-
thione (Lee et al., 1998). Increases in steady-state levels of
hydroperoxide during glucose deprivation seem to cause ox-
idative stress and cytotoxicity, which are inhibited by a thiol
antioxidant such as N-acetyl-L-cysteine (NAC) (Blackburn et
al., 1999). The fact that NAC inhibits glucose deprivation-
induced increases in steady-state hydroperoxide levels, accu-
mulation of oxidized glutathione, and cytotoxicity leads to
the hypothesis that changes in the redox status of thiols are
responsible for cell death during glucose deprivation. It is
well known that all oxygen-metabolizing cells produce a rel-
atively constant low level of pro-oxidants (i.e., superoxide,
hydrogen peroxide, etc.) as by-products of electron transport
chain activity. The redox state is balanced by the cellular
antioxidant capacity to maintain a viable nonequilibrium
steady-state environment that is predominantly reducing.
The major mechanism by which cells regulate redox pro-
cesses is the reversible formation of disulfides through the
oxidation of cysteine residues (Aslund and Beckwith, 1999).
One of the well-known redox regulatory systems involving
disulfide formation is the thioredoxin/thioredoxin reductase
system (Holmgren, 1985). Thioredoxin (TRX) is a 104 amino
acid protein with a molecular mass of 12 kDa. It is a multi-
functional and ubiquitous protein. It acts as a growth factor
(Wakasugi et al., 1990), an antioxidant (Spector et al., 1988),
a transcription factor regulator (Matthews et al., 1992),
and an antiapoptotic molecule (Iwata et al., 1997). Recent
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studies reveal that TRX is a binding partner of apoptosis
signal-regulating kinase 1 (ASK1) (Saitoh et al., 1998).
TRX associated with the N-terminal portion of ASK1 and
the interaction between them is highly dependent on the
redox state of TRX. The dissociation of TRX from ASK1
activates the ASK1-MEK-MAPK signal transduction path-
way, thus promoting cell death via apoptosis (Ichijo et al.,
1997). In this study, we hypothesized that inhibiting TRX
function would augment glucose deprivation-induced cyto-
toxicity by promoting the ASK1-MEK-MAPK signal trans-
duction pathway. Among a series of imidazolyl disulfide
compounds that inhibit TRX activity through thioalkyla-
tion of critical cysteine residues (Kirkpatrick et al., 1998),
we chose the most potent and selective TRX inhibitor,
1-methylpropyl 2-imidazolyl disulfide (IV-2). Our studies
demonstrate that glucose deprivation-induced cytotoxicity
and oxidative DNA damage are significantly enhanced by
treatment with IV-2. This is probably caused by the pro-
motion of a glucose deprivation-activated ASK1-SEK1-
JNK1 pathway by treatment with IV-2.
Materials and Methods
Cell Culture and Survival Determination. Human prostatic
adenocarcinoma DU-145 cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) with 10% fetal bovine serum (Hyclone,
Logan, UT) and 26 mM sodium bicarbonate. The Petri dishes con-
taining cells were kept at 37°C in a humidified incubator with a
mixture of 95% air and 5% CO2. Two days before the experiment,
cells were plated into 60-mm Petri dishes. For survival determina-
tion, cells were treated with trypsin, formed into pellets, and resus-
pended in 0.2 ml of DMEM, 0.5 ml of 0.4% trypan blue solution, and
0.3 ml of phosphate-buffered saline solution (PBS). The samples
were mixed thoroughly, incubated at room temperature for 15 min,
and examined.
Measurement of 8-OHdG Content. The content of 8-hydroxyl-
2-deoxyguanosine (8-OhdG) in nuclear DNA was measured using
high-performance liquid chromatography with electrochemical de-
tection (HPLC-EC) as described previously (Lan et al., 2000). The
stock standard solution containing 8-OHdG or 2-deoxyguanosine
(2-dG) (Sigma, St. Louis, MO) was prepared at 1 mg/ml and stored at
4°C. This stock then underwent a 100-fold dilution (10 g/ml) and
was used directly as a standard. All other chemicals were the purest
that was commercially available. The water used in all experiments
was obtained from a Milli-Q water purification system (Millipore
Corporation, Bedford, MA) and measured at 18.2 M-cm.
The method for DNA extraction and subsequent digestion was the
same as that described previously (Lan et al., 2000). This protocol
avoided the use of phenol or any known oxidants that may induce
background 8-OHdG. Briefly, cells were kept in a hypotonic buffer
for the isolation of nuclei (Nagayama et al., 2000). The pellet con-
taining the nuclei was then suspended at 1:5 (v/v) in the lysis buffer
containing 1 M LiCl, 2 M urea, 40 mM sodium citrate, 5 mM EDTA,
and 2% SDS. RNase A (final concentration, 0.1 mg/ml) and protein-
ase K (final concentration, 0.2 mg/ml) were added to each sample and
incubated for 2 h at 50°C. The aqueous solution containing the
nucleic acids was extracted with three changes of chloroform/isoamyl
alcohol (24:1, v/v). The aqueous solution and chloroform/isoamyl
alcohol were mixed for 15 min between changes and centrifuged for
20 min at 10,000g (Beckman J2-MC; Beckman Coulter, Inc., Fuller-
ton, CA). The final aqueous extraction was removed, and a 1/15
volume of 3 M sodium acetate, pH 7.0, and 2 volumes of 95% cold
ethanol were added. DNA was precipitated at 20°C overnight. The
sample was centrifuged at 13,000g for 30 min to form a pellet. The
DNA pellet was air-dried and resuspended in 100 l of buffer con-
taining 10 mM Tris, pH 7.4, and 1 mM EDTA. The DNA concentra-
tion was measured using a spectrophotometer (Beckman Coulter,
Fullerton, CA).
DNA digestion was performed using nuclease P1 and alkaline
phosphatase to circumvent possible contamination by trace metals in
DNase I. A 10-l aliquot of 0.5 M sodium acetate, pH 5.1, and 1.0 l
of 1 M magnesium chloride were added to the above DNA solution.
The sample was then boiled at 100°C for 5 min and immediately
cooled on ice for 5 min. A 4-l aliquot of nuclease P1 (1 mg/ml) was
added, and the sample was then incubated for 1 h at 37°C. After
adjusting the pH to 7.8 by adding a 4-l aliquot of 1 M Tris, pH 10.6,
1 l of alkaline phosphatase (1 U/l) was added. The sample was
then incubated for 1 h at 37°C. Enzymes were precipitated by adding
2 l of 5.8 M acetic acid, and then the sample was filtered through a
0.2-m HPLC filter. A 20-l sample containing 2 g of DNA was
then injected into the HPLC. Samples were further diluted to 1:100
in water for the analysis of 2-dG.
The isocratic analysis was conducted using a CoulArray system
(model 5600) equipped with a dual piston pump (model 580) and a
PEEK pulse damper (ESA, Inc., Chelmsford, MA). The analysis was
performed using two coulometric array cell columns. The data were
acquired and analyzed using the CoulArray software. The data were
expressed as the amount of 8-OHdG in 105 2-dG determined in the
same sample (Lan et al., 2000). Using a syringe sample injector
(model 9125; RHEODYNE, Cotani, CA), the samples were separated
on a 3-m 150  4.6-mm YMC basics C18 column (YMC, Wilming-
ton, NC). The mobile phase contained 100 mM sodium acetate, pH
5.2, with phosphoric acid and methanol (95:5, v/v). The detector
potentials were 200/290/380/520/730/800/870/940 mV (versus poten-
tial difference). The flow rate for the system was 1.0 ml/min.
Glucose Deprivation and Drug Treatment. Cells were rinsed
three times (for 5 min each) with PBS solution, which took approx-
imately 15 min. Cells were exposed to glucose-free DMEM with 10%
dialyzed fetal bovine serum (Invitrogen, Carlsbad, CA). For drug
treatment, cells were replaced with medium containing IV-2 (10–50
M; a gift from Dr. D. L. Kirkpatrick, ProlX Pharmaceuticals, Pitts-
burgh, PA) and/or N-acetyl-L-cysteine (1–10 mM; Sigma).
Morphological Evaluation. Approximately 7  105 cells were
plated into 60-mm Petri dishes overnight. Cells were exposed to
glucose-free medium with or without IV-2 and then analyzed by
phase-contrast microscopy.
Transfection. Cells were transfected with 0.5 to 2 g of plasmids
containing dominant-negative mutant c-Jun N-terminal kinase 1
(JNK1) cDNA [pcDNA3-FLAG-JNK1(APF); provided by R. Davis,
University of Massachusetts Medical Center, Worcester, MA] by
using Lipofectin reagent (Invitrogen). Cells were incubated for 48 h
before the experiment.
Adenoviral Vector Construction. The adenovirus construct
containing the transgene for human catalase was kindly provided by
Dr. Beverly Davidson (Gene Transfer Vector Core, University of
Iowa, Iowa City, IA). To construct a replication-incompetent adeno-
viral vector containing the cytomegalovirus promoter-driven thiore-
doxin gene (Ad.TRX), we used the Cre-lox recombination system
(Hardy et al., 1997). In brief, a his-tagged 324-base pair TRX gene
was isolated from pcDNA3.His-TRX (Hirota et al., 2000) by restric-
tion digestion with EcoRI and cloned into the EcoRI site of the
pAdlox shuttle vector. The complete shuttle vector was cotransfected
into Cre8 cells with 5 viral genomic DNA for homologous recombi-
nation. Plaques were harvested, analyzed, and purified.
In Vivo Binding of ASK1 and TRX. To examine the interaction
between ASK1 and TRX, adenovirus of HA-tagged ASK1 (10 m.o.i.)
and His-tagged TRX (20 m.o.i.) were coinfected into DU-145 cells in
10-cm Petri dishes. For immunoprecipitation, cells were lysed in a
lysis buffer containing 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, 10
mM EDTA, 1% Triton X-100, 1% deoxycholate, 1 mM phenylmeth-
ylsulfonyl fluoride (PMSF), 80 M aprotinin, and 2 mM leupeptin.
Lysates were clarified by centrifugation at 15,000g for 15 min at 4°C.
Proteins from the supernatant were immunoabsorbed with 2 g of
anti-penta His mouse IgG1 (QIAGEN, Valencia, CA) for 2 h. After
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the addition of protein G/A agarose (Calbiochem, Darmstadt, Ger-
many), the lysates were incubated for an additional 2 h. The beads
were washed three times with the lysis buffer, separated by SDS-
polyacrylamide gel electrophoresis (PAGE), and immunoblotted with
rat anti-HA monoclonal antibody (clone 3F10; Roche Diagnostics,
Mannheim, Germany) or mouse anti-penta His monoclonal antibody
(QIAGEN). The proteins were detected with the enhanced chemilu-
minescence system (Amersham Biosciences Inc., Piscataway, NJ).
In Vitro Kinase Assay. The plasmid of GST-human JNK1 for
bacterial fusion protein was constructed in pGEX-4T-1 by inserting
HindIII/XbaI fragment followed by Klenow treatment from
pcDNA3-JNK1. The expression of GST-JNK1 protein was confirmed
by Western blotting and was purified by using glutathione Sepha-
rose 4B (Amersham Biosciences). GST-SEK1 was purified from 293
cells transfected with the pEBG/SEK1 (kindly provided by J.M.
Kyriakis, Massachusetts General Hospital, Charlestown, MA), and
the purification step was performed as described previously (Yuasa
et al., 1998). DU-145 cells were infected with 10 m.o.i. of Ad.HA-
ASK1 for 24 h. After 24 h, cells were lysed in a buffer solution
containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EGTA, 10
mM NaF, 1% Triton X-100, 0.5% deoxycholate, 3 mM dithiothreitol,
1 mM sodium orthovanadate, 1 mM PMSF, and protein inhibitor
cocktail solution (Sigma). Cell extracts were clarified by centrifuga-
tion, and the supernatants were immunoprecipitated with mouse
anti-HA antibody (12CA5, Roche) and protein G/A agarose. The
beads were washed twice with a solution containing 150 mM NaCl,
20 mM Tris-HCl, pH 7.5, 5 mM EGTA, 2 mM dithiothreitol, and 1
mM PMSF and washed once with the kinase buffer solution. To
measure immune complex kinase activity, 0.2 g of GST-SEK1 was
first incubated with the immune complexes for 10 min at 30°C in a
final volume of 25 l of a solution containing 20 mM Tris-HCl, pH
7.5, 20 mM MgCl2, and 100 M ATP and subsequently with 1 g of
GST-JNK1 for 10 min at 30°C. Thereafter, the activated complex was
subjected to SDS-PAGE, and the phosphorylated JNK1 was detected
with anti-ACTIVE JNK polyclonal antibody (Promega, Madison,
WI). To determine the amount of ASK1 protein in the same sample,
the upper part of the SDS-PAGE (116 kDa) was cut out and
immunoblotted with the mouse anti-HA antibody (Roche).
Protein Extracts and PAGE. Cells were lysed with 1 Laemmli
lysis buffer (2.4 M glycerol, 0.14 M Tris, pH 6.8, 0.21 M SDS, 0.3 mM
bromphenol blue) and boiled for 10 min. Protein content was mea-
sured with the use of bicinchoninic acid protein assay reagent (Pierce
Chemical, Rockford, IL). The samples were diluted with 1 lysis
buffer containing 1.28 M -mercaptoethanol, and equal amount of
protein was loaded on 8–13.5% SDS-PAGE. SDS-PAGE analysis was
performed according to the method described by Laemmli (1970)
using a Hoefer gel apparatus.
Immunoblot Analysis. Proteins were separated with the use of
SDS-PAGE and electrophoretically transferred to a nitrocellulose
membrane. The nitrocellulose membrane was blocked with 7% non-
fat dry milk in PBS-Tween 20 (0.1%, v/v) at 4°C overnight. The
membrane was incubated with anti-HA, anti-His, anti-JNK1 poly-
clonal (Santa Cruz Biochemicals, Santa Cruz, CA), or anti-ACTIVE
JNK antibody (diluted according to the manufacturer’s instructions)
for 1 h. Horseradish peroxidase-conjugated anti-rabbit, anti-rat, or
anti-mouse IgG was used as the secondary antibody. Immunoreac-
tive protein was visualized by the enhanced chemiluminescence pro-
tocol (Amersham Biosciences).
Results
IV-2 Enhances Glucose Deprivation-Induced Cyto-
toxicity. The effect of glucose deprivation on cell death in
combination with IV-2, a thioredoxin inhibitor, was assessed
in the human prostatic adenocarcinoma DU-145 cell line.
Figure 1A shows that DU-145 cells starved for glucose exhib-
ited a time-dependent reduction in cell survival. IV-2 alone
caused little or no cytotoxicity within 7 h. Figure 1A also
shows that the glucose deprivation-induced cytotoxicity was
markedly enhanced by adding IV-2 into the medium. Sur-
vival was dependent on the concentration of IV-2 added
(10–50 M). For example, the survival of the cells decreased
to 13% by 3 h of incubation in glucose-free medium with 50
M IV-2. These observations were consistent with morpho-
logical features (Fig. 1B). Cells treated with IV-2 in the
absence of glucose underwent morphological alteration
(rounding and blebbing formation) (Fig. 1B, d and e). Mor-
phological changes were dependent on the dose of IV-2. More
blebbing and rounding cells were observed at the higher
concentrations of the drug. Figure 1C also shows that the
combination of glucose deprivation and IV-2–induced cyto-
toxicity was inhibited by adding glucose into the glucose-free
medium. DU-145 cells were treated with 50 M IV-2 in the
presence of various concentrations of glucose (0.001–10 mM).
Survival was dependent on the concentration of glucose
added into the glucose-free medium. Little or no change in
survival was gained by adding glucose up to a concentration
of 0.01 mM, and then the survival of the cells increased
linearly to 92% by adding glucose up to 1 mM. These results
suggest that IV-2 promotes low glucose-induced cytotoxicity.
Glucose Deprivation in Combination with IV-2 En-
hances Oxidative DNA Damage. We observed previously
that glucose deprivation increases the intracellular level of
reactive oxygen species (ROS) (Lee et al., 1998). It is well
known that ROS causes oxidative DNA damage. To examine
whether IV-2 enhances glucose deprivation-induced oxida-
tive DNA damage, DU-145 cells were exposed to glucose-free
medium in the presence of 50 M IV-2 for 3 h. After treat-
ment, formation of the DNA base modification 8-OHdG was
detected using HPLC-EC. Figure 2 shows a 2.5-fold increase
in 8-OHdG content in the cells exposed to glucose-free me-
dium in the presence of IV-2 compared with that in the
absence of IV-2. Treatment with IV-2 itself caused an in-
crease in 8-OHdG content. This is probably caused by the
inhibition of TRX, which can scavenge ROS (Takemoto et al.,
1998).
Effect of the addition of N-Acetyl-L-Cysteine on Cells
Starved for Glucose and Exposed to IV-2. We reported
previously that glucose deprivation induces metabolic oxida-
tive stress (Lee et al., 1998). The metabolic oxidative stress-
induced cytotoxicity is enhanced by IV-2, a thioredoxin in-
hibitor (Fig. 1). To confirm whether the effects of IV-2 on
glucose deprivation are caused by an increase in oxidative
stress, DU-145 cells were treated with an antioxidant, NAC,
during incubation with glucose-free medium in the presence
of IV-2. Figure 3A shows that IV-2 plus glucose deprivation-
induced cytotoxicity was completely inhibited by treatment
with NAC (1–10 mM). In addition, the morphological changes
caused by glucose starvation and IV-2 were prevented by
adding 1 mM NAC during treatment with 50 M IV-2 in the
absence of glucose (Fig. 3B, d).
Effect of Thioredoxin on the Cytotoxicity from the
Combined Treatment of IV-2 and Glucose Deprivation.
To examine whether the overexpression of TRX could prevent
cytotoxicity induced by IV-2 plus glucose deprivation, DU-
145 cells were infected with Ad.TRX. Figure 4 shows a West-
ern immunoblot demonstrating exogenous TRX protein ex-
pression as detected with a His-specific monoclonal antibody.
Expression of TRX protein increased with increasing m.o.i.
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(Fig. 4A) and increasing incubation period after infection
(Fig. 4B). Expression of TRX was detected at an m.o.i. of 10
pfu/cell and greater. It was also detected after 16 h of incu-
bation. To evaluate the effect of TRX overexpression on IV-
2–enhanced glucose-deprivation cytotoxicity, DU-145 cells
were infected with Ad.TRX at various m.o.i. values and then
exposed to medium containing 0.1 mM glucose and 50 M
IV-2 for 4 h. We chose to use 0.1 mM glucose instead of
Fig. 1. Effect of IV-2 on glucose deprivation-induced cytotoxicity in DU-145 cells. A, cells were exposed to glucose-free medium in the presence of IV-2
(10–50 M) for various times, and cell survival was determined by use of the Trypan blue exclusion assay. (f), 50 M IV-2 alone; (), glucose-free
medium alone; (‚), glucose-free medium plus 10 M IV-2; (ƒ), glucose-free medium plus 25 M IV-2; (), glucose-free medium plus 50 M IV-2. Data
are a compilation of two separate experiments. B, cells were exposed to glucose-free medium alone (Glu; b), 50 M IV-2 alone (50 M IV-2; f), or
glucose-free medium in the combination with 10 M IV-2 (Glu  10 M IV-2; c), 25 M IV-2 (Glu  25 M IV-2; d), or 50 M IV-2 (Glu  50
M IV-2; e) for 4 h, and then morphological features were analyzed with phase-contrast microscopy. CON, untreated control cells (a). C, cells were
treated with 50 M IV-2 in the presence of various concentrations (0.001–10 mM) of glucose for 4 h, and cell survival was determined by use of the
Trypan blue exclusion assay. Data are a compilation of two separate experiments.
1412 Lee et al.
 at A
SPET Journals on Septem
ber 10, 2015
m
olpharm
.aspetjournals.org
D
ow
nloaded from
 
glucose-free medium because, as shown in Fig. 1C, transi-
tional changes in the survival level can be easily detected
in this range. Figure 4C shows that Ad.TRX infected cells
became resistant to combined glucose deprivation and IV-2
treatment-induced cytotoxicity. Cells infected with
Ad.TRX at an m.o.i. of 300 pfu/cell survived approximately
1.8-fold better than control adenoviral vector-infected
cells.
Activation of ASK1 by Glucose Deprivation and/or
IV-2 Treatment. Previous studies have shown that glucose
deprivation induces an increase in intracellular hydroperox-
ide levels (Lee et al., 1998). In this study, we hypothesized
that TRX recognizes metabolic oxidative stress and subse-
quently triggers ASK1 signal transduction pathway by dis-
rupting the interaction between TRX and ASK1. To test our
hypothesis, DU-145 cells were coinfected with adenoviral
vectors containing His-tagged TRX (Ad.TRX) and HA-tagged
ASK1 (Ad.ASK1). Cells were exposed to glucose-free medium
in the presence or absence of IV-2. Data from immunopre-
cipitation followed by immunoblot assay demonstrate that
TRX dissociated from ASK1 during glucose deprivation (Fig.
5). The level of dissociation was enhanced by treatment with
IV-2. These data suggest that IV-2 promotes the dissociation
of TRX from ASK1.
Combination of Glucose Deprivation and IV-2 Treat-
ment Promotes JNK Activation. We observed previously
that glucose deprivation activates c-Jun N-terminal kinase 1
(JNK1 and overexpression of its dominant-negative mutant
inhibits metabolic oxidative stress-induced cytotoxicity (Lee
et al., 2000). We examined whether combined glucose depri-
vation and IV-2 treatment enhances JNK activation. JNK1
was activated within 5 min, and its activation was main-
tained for more than 2 h during glucose deprivation (Fig. 6A).
Figure 6A also shows that glucose deprivation-induced JNK1
activation was promoted by treatment with IV-2. The level of
activated JNK1 was dependent on the dose of IV-2. IV-2 itself
also activates JNK1 (Fig. 6B). To examine whether combined
glucose deprivation and IV-2 treatment promotes JNK1 ac-
tivation by activating the ASK1-SEK1-JNK1 pathway, cells
were infected with Ad.ASK1, and ASK1 kinase activity was
measured by an immune complex-coupled kinase assay using
glutathione S-transferase (GST)-SEK1 and GST-JNK1 as
sequential substrates. Activated JNK1 was detected by anti-
ACTIVE JNK1 antibody. Figure 7 shows the specificity of
Fig. 2. Induction of 8-OHdG in nuclear DNA after glucose deprivation,
IV-2 treatment, or glucose deprivation in combination with IV-2. DU-145
cells exposed to glucose free-medium alone (Glucose), 50 M IV-2 alone
(IV-2), or glucose-free medium in the presence of 50 M IV-2 (Glucose
 IV-2) for 3 h. Cells were harvested, and then 8-OHdG and 2-dG
concentrations were measured using the HPLC-EC method. Data are
mean  S.D. from triplicate samples.
Fig. 3. Effect of NAC on the combination of glucose deprivation and IV-2
treatment-induced cytotoxicity. A, cells were incubated for 4 h with
combined treatment of 50 M IV-2 and glucose deprivation in the pres-
ence of NAC, and then cell survival was determined by the Trypan blue
exclusion assay. a, glucose-free medium alone; b, glucose-free medium
plus 50 M IV-2; c, glucose-free medium plus 50 M IV-2 plus 1 mM
NAC; d, glucose-free medium plus 50 M IV-2 plus 10 mM NAC. Data are
a compilation of two separate experiments. B, morphology was also ex-
amined with phase-contrast microscopy. Control, untreated control cells
(a); Glu, cells were exposed to glucose-free medium alone for 4 h (b);
Glu  IV-2, glucose-free medium plus 50 M IV-2 (c); Glu  IV-2 
NAC, glucose-free medium plus 50 M IV-2 plus 1 mM NAC (d).
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ASK1-dependent phosphorylation of JNK1 in this assay.
When cells were exposed to glucose-free medium, JNK1 was
activated, and the activation of JNK1 was promoted by treat-
ment with IV-2. These results illustrate that glucose depri-
vation activates the ASK1-SEK1-JNK1 signal transduction
pathway, and the combined treatment of IV-2 and glucose
deprivation facilitates this activation.
Fig. 5. Effect of IV-2 and/or glucose deprivation on the interaction of TRX
with ASK1. Cells were coinfected with adenoviral vectors containing
His-tagged TRX (Ad.TRX) and HA-tagged ASK1 (Ad.ASK1) at an m.o.i. of
20 and 10 pfu/cell, respectively. After 24 h of incubation, cells were
exposed to glucose-free medium for 10 min (lane 3) or 30 min (lane 4), or
to 50 M IV-2 for 10 min (lane 5) or 30 min (lane 6), or to glucose-free
medium plus IV-2 for 10 min (lane 7) or 30 min (lane 8). Proteins were
immunoprecipitated with anti-His antibody and then immunoblotted
with anti-HA antibody (top) or anti-His antibody (bottom).
Fig. 6. Immunoblot detection of active JNk. A, cells were exposed to
glucose-free medium (Glucose) or glucose-free medium plus 10 to 50 M
IV-2 (Glucose  IV-2). B, cells were exposed to 50 M IV-2 alone (IV-2)
for various times (5–120 min). After incubation, cells were harvested and
Western blot analysis was performed as described in Fig. 4 with anti-
ACTIVE JNK or anti-actin antibodies as the loading control.
Fig. 7. Effect of IV-2 on glucose deprivation-activated ASK1-SEK1-JNK1
signal transduction. Cells were infected with Ad.ASK1 at an m.o.i. of 10
pfu/cell. After 24 h of incubation, cells were exposed to glucose-free
medium for 1 h (lane 3) or glucose-free medium plus 50 M IV-2 for 1 h
(lane 4). Lane 1, uninfected control cells; lane 2, Ad.ASK1 infection only.
Proteins were immunoprecipitated with anti-HA antibody. The immune
complex was incubated with GST-SEK1 and GST-JNK1 and then acti-
vated JNK1 (P-JNK1) was detected with anti-ACTIVE JNK.
Fig. 4. Examination of TRX expression and its effect on glucose plus
IV-2–induced cytotoxicity in adenovirus-infected cells. A, effect of m.o.i.
on expression of TRX protein. Cells were infected with Ad.TRX at various
m.o.i. values (0–100 pfu/cell) for 3 h and incubated for 24 h before
harvested. B, time-dependent accumulation of TRX protein. Cells were
infected with Ad.TRX at an m.o.i. of 100 pfu/cell for 3 h and incubated for
various times (0–24 h) before harvesting. Lysates containing equal
amounts of protein (20 g) were separated by the use of SDS-PAGE and
immunoblotted by using anti-His monoclonal antibody-detected His-
tagged TRX (His-TRX). Actin, actin was used to confirm that an equal
amount of protein loaded in each lane. C, cells were infected with Ad.TRX
() or control adenoviral vector (f) at various m.o.i. values (0–300
pfu/cell) for 3 h. After incubation for 24 h, cells were exposed to medium
containing 0.1 mM glucose and 50 M IV-2 for 4 h before survival
determination.
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Effect of JNK1 Dominant-Negative Protein on the
Combined Treatment of IV-2 and Glucose Deprivation-
Induced JNK1 Activation and Cytotoxicity. JNK1 acti-
vation has been implicated previously as the mechanism
responsible for glucose deprivation-induced cytotoxicity;
therefore, we examined the effect of JNK1 dominant-nega-
tive protein on the combined treatment of IV-2 and glucose
deprivation. Cells were transiently transfected with control
plasmid (pcDNA3-neo) or various concentrations (0.5 or 2
g/ml) of dominant-negative JNK1 expression plasmid
[pcDNA3-FLAG-JNK1(APF)]. JNK1 dominant-negative mu-
tant protein was successfully expressed (Fig. 8A). Compared
with wild-type JNK1 in either untransfected control cells or
control plasmid-transfected cells, dominant-negative JNK1
was expressed approximately 12- to 19-fold in pcDNA3-
FLAG-JNK1(APF) transfected cells, as determined by densi-
tometric analysis. Control plasmid-transfected or dominant-
negative JNK1 plasmid-transfected cells were treated with
50 M IV-2 in the absence of glucose. JNK1 was activated by
glucose deprivation in combination with IV-2 (Fig. 8B, lane
2). Expression of JNK1 dominant-negative mutant protein
suppressed this activation (Fig. 8B, lanes 4 and 6). We also
tested the effect of expression of JNK1 dominant-negative
mutant protein on the combined treatment of IV-2 and glu-
cose deprivation-induced cytotoxicity. Expression of JNK1
dominant-negative mutant protein protected cells from this
cytotoxicity (Fig. 8C). The degree of protection was depen-
dent on the amounts of JNK1 dominant-negative mutant
protein (Fig. 8A).
Overexpression of Catalase Inhibits Glucose Depri-
vation Plus IV-2–Induced Dissociation of TRX from
ASK1, JNK Activation, and Cytotoxicity. To assess the
involvement of ROS in glucose deprivation plus IV-2–induced
dissociation of TRX from ASK1, JNK activation, and cytotox-
icity, DU-145 cells were infected with adenoviral vectors
containing catalase, an H2O2 scavenger. Figure 9A shows
that overexpression of catalase suppressed glucose depriva-
tion plus IV-2–induced dissociation of TRX from ASK1 (Fig.
9A, lane 4 versus lane 3). Overexpression of catalase also
inhibited glucose deprivation-induced JNK1 activation (Fig.
9B, lane 2 versus lane 5) as well as glucose deprivation plus
IV-2–induced JNK1 activation (Fig. 9B, lane 3 versus lane 6).
Overexpression of catalase prevented enhancement of glu-
cose deprivation-induced cytotoxicity by IV-2 treatment (Fig.
9C).
Discussion
Several conclusions can be drawn when considering the
data presented. Glucose deprivation-induced cytotoxicity as
well as JNK1 activation were augmented by treatment with
IV-2, a TRX inhibitor. Overexpression of TRX or the domi-
nant-negative mutant of JNK1 inhibited cytotoxicity and
activation of JNK1. These results suggest that inhibiting
TRX promotes metabolic oxidative stress and enhances cyto-
toxicity by increasing JNK1 activation.
In higher eukaryotes, ROSs are generated during respira-
tion in mitochondria in the course of reduction of molecular
oxygen. Our recent studies have demonstrated that glucose
deprivation enhances the intracellular level of hydroperoxide
(Lee et al., 1998). The most likely interpretation of our ob-
servations is that a decrease in the rate of elimination of ROS
via glutathione peroxidase/glutathione reductase, rather
than an increased rate of mitochondrial oxidant production,
is responsible for the increase in the level of hydroperoxide.
The ROS produced in the mitochondria may not be elimi-
nated sufficiently fast if NADPH is not produced quickly
enough via the pentose phosphate pathway. Glucose depri-
vation also results in an increase in steady-state levels of
Fig. 8. Expression of JNK1 dominant-negative protein and its effect on
glucose deprivation plus IV-2–induced JNK activation and cytotoxicity.
A, cells were transfected with 2 g/ml control plasmid (pcDNA3-neo) or
0.5 to 2 g/ml dominant-negative JNK1 expression plasmid [pcDNA3-
FLAG-JNK1(APF)]. After 48 h of incubation, cells were harvested. Cell
lysate proteins were separated and immunoblotted by using anti-JNK1
polyclonal antibody. Lane 1, untransfected control cells; lane 2, pcDNA3-
neo transfected cells; lane 3, 0.5 g/ml pcDNA3-FLAG-JNK1(APF)-trans-
fected cells; lane 4, 2 g/ml pcDNA3-FLAG-JNK1(APF)-transfected cells.
Actin was shown as an internal standard. B, cells were transfected with
2 g/ml pcDNA3-neo (lanes 1 and 2), 0.5 g/ml pcDNA3-FLAG-
JNK1(APF) (lanes 3 and 4), or 2 g/ml pcDNA3-FLAG-JNK1(APF) (lanes
5 and 6). After 48 h of incubation, cells were harvested (lanes 1, 3, and 5)
or exposed to glucose-free medium plus 50 M IV-2 for 1 h (lanes 2, 4, and
6). Lysates containing equal amounts of protein were separated and
immunoblotted by using anti-ACTIVE JNK polyclonal antibody. Actin
was used to confirm that an equal amount of protein loaded in each lane.
C, cells were transfected with 2 g/ml pcDNA3-neo (Neo), 0.5 g/ml
pcDNA3-FLAG-JNK1(APF) (#1), or 2 g/ml pcDNA3-FLAG-JNK1(APF)
(#2). After 48 h of incubation, cells were exposed to glucose-free medium
plus 50 M IV-2 for 4 h, and cell survival was determined by the Trypan
blue exclusion assay. Error bars represent S.D. from triplicate experi-
ments.
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intracellular oxidized glutathione. In the absence of sub-
strates necessary for the regeneration of NADPH, glutathi-
one cannot be maintained in the reduced state (Blackburn et
al., 1999). It is well known that cells have developed two
important defense mechanisms against oxidative stress (Na-
kamura et al., 1997). One is a thiol reducing buffer consisting
of small proteins with redox-active sulfhydryl moieties (e.g.,
glutathione and thioredoxin). The other is an enzymatic sys-
tem (e.g., superoxide dismutase, catalase, and glutathione
peroxidase). Our results suggest that the combination of
glucose deprivation and IV-2 treatment enhances cytotoxic-
ity by decreasing the level of the endogenous thiol buffers.
The changes in redox state disrupt the interaction between
TRX and ASK1 (Saitoh et al., 1998), subsequently activating
the ASK1-SEK1-JNK1 pathway (Ichijo et al., 1997). Overex-
pression of catalase, an H2O2 scavenger, inhibits glucose
deprivation plus IV-2–induced dissociation of TRX from
ASK1, JNK1 activation, and cytotoxicity (Fig. 9).
Recent studies reveal that TRX, a redox-regulatory pro-
tein, is a negative regulator of ASK1 (Saitoh et al., 1998).
TRX binds directly to the N-terminal portion of ASK1 and
inhibits ASK1 kinase activity (Saitoh et al., 1998). The inter-
action between TRX and ASK1 is dependent on the redox
status of TRX. TRX contains two redox-active half-cystine
residues (Trp-Cys-Gly-Pro-Cys-Lys) in an active center
(Holmgren, 1989), which may recognize oxidative stress
through catalysis of thiol-disulfide interchange reactions
with oxidized molecules. The oxidized TRX, which contains a
disulfide bridge in the active site, dissociates from ASK1. The
dissociation of TRX and ASK1 results in the activation of
ASK1 (Saitoh et al., 1998). ASK1 is a MAPK kinase kinase
that can activate both the stress-activated protein kinases
(via activation of SEK1) and the p38s (via activation of
MKK3 and MKK6) (Ichijo et al., 1997). In this study, we
observed that TRX dissociates from ASK1 during glucose
deprivation and subsequently activates the ASK1-SEK1-
JNK1 signal transduction pathway. IV-2 treatment enhances
glucose deprivation-induced JNK1 activation by promoting
dissociation of TRX from ASK1.
Several studies have demonstrated that the JNK signal
transduction pathway is activated by a variety of cellular
stimuli, including mitogenic signals (Minden et al., 1994),
oxidative stress (Cui and Douglas, 1997; Qin et al., 1997),
DNA-damaging agents (Yu et al., 1996a; Zanke et al., 1996),
and chemopreventive drugs (Yu et al., 1996b; Chen et al.,
1998). After activation, JNK phosphorylates several tran-
scription factors (Cavigelli et al., 1995; Gupta et al., 1995). It
is believed that JNK is involved in both cell-growth and
cell-death pathways (Xia et al., 1995; Smith et al., 1997).
However, the factors which determine the various outcomes
of JNK signaling are still unknown. Chen et al. (1996a,b,
1998) reported that a prolonged activation of JNK was asso-
ciated with the initiation of cell death. In this study, we
demonstrated that IV-2 treatment not only sustained JNK
activation, but also promoted JNK activation caused by glu-
cose deprivation in DU-145 cells (Fig. 7). This is probably
how IV-2 contributes to metabolic oxidative stress-induced
cell death. A fundamental question that remains unanswered
is how JNK1 activation leads to cell death. Recent studies
have shown that mitochondria are influenced by proapoptotic
signal transduction through the JNK pathway (Tournier et
al., 2000). JNK is probably involved in Bid cleavage, cyto-
Fig. 9. Effect of catalase on glucose deprivation plus IV-2–induced dissoci-
ation of TRX from ASK-1, JNK activation, and cytotoxicity. A, cells were
infected with Ad.TRX at an m.o.i. of 30 pfu/cell, Ad.ASK1 at an m.o.i. of 10
pfu/cell, or adenoviral vectors containing catalase (Ad.Catalase) at an m.o.i.
of 100 pfu/cell, respectively. After 24 h of incubation, cells were exposed to
complete medium (lane 2) or glucose-free medium in the presence of 50 M
IV-2 for 1 h (lanes 3 and 4). Cell lysates were divided into two portions. One
portion was immunoprecipitated with anti-His antibody, and then immuno-
blotted with anti-HA antibody (HA-ASK1) or anti-His antibody (His-TRX).
The other portion was immunoblotted with anti-catalase antibody or anti-
actin antibody. Actin was used to confirm that similar amounts of proteins
were loaded in each lane. B, cells were infected with adenoviral vectors
containing green fluorescence protein (Ad.EGFP) or Ad.Catalase at an m.o.i.
of 100 pfu/cell. After 24 h of incubation, cells were exposed to complete
medium () or glucose-free medium () with () or without () 50 M IV-2
for 1 h. Cells were harvested, and Western blot analysis was performed as
described in Fig. 4 with anti-ACTIVE JNK, anti-catalase, or anti-actin
antibodies as the loading control. C, cells were infected with adenoviral
vectors containing green fluorescence protein (Ad.EGFP) or Ad.Catalase at
an m.o.i. of 100 pfu/cell. After 24 h of incubation, cells were exposed to
glucose-free medium with or without 50 M IV-2 for 3 h. Cell survival was
determined by the Trypan blue exclusion assay. Error bars represent S.D.
from triplicate experiments.
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chrome c release, or mitochondrial depolarization. These
studies suggest that Bid is cleaved by caspase 8 (Li et al.,
1998; Luo et al., 1998) or a JNK-mediated caspase-indepen-
dent mechanism (Tournier et al., 2000). A second potential
target of JNK signaling is Bcl-2. Previous studies have shown
that the antiapoptotic protein Bcl-2 is phosphorylated by
IV-2 treatment (Vogt et al., 2000). Bcl-2 is inactivated by
phosphorylation, and its phosphorylation is mediated
through activated JNK (Maundrell et al., 1997; Yamamoto et
al., 1999). Nonetheless, we shall not rule out any other pos-
sibilities. Our data also suggest that not only the disruption
of TRX-ASK1 interaction and subsequent stimulation of JNK
signaling but also the increase of DNA damage contribute to
the hypersensitive phenotype seen with the combined glu-
cose deprivation and IV-2 treatment (Figs. 1 and 2). These
genotoxic events are probably inhibited by scavenging H2O2
in the catalase-overexpressing cells (Fig. 9C). This possibility
needs to be further investigated. Although we believe that
many critical questions still remain to be answered to under-
stand the mechanisms of IV-2–augmented glucose depriva-
tion-induced cytotoxicity, our proposed model provides im-
portant information for understanding how signal
transduction pathways or genotoxic events are involved in
metabolic oxidative stress-induced cell death.
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